Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer and the fourth leading cause of cancer-related death, has a 5-year survival rate of less than 10%.1 The impact of pancreatic ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

The prototype of a new machine that can detect tumors in women with dense breast tissue has been developed by researchers from UCL, Newcastle Hospitals and Newcastle University, in partnership with ...

Published in Nature Communications, the study introduces a new imaging system that uses lasers to detect critical changes in ...